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Growth rates or radiobiological hypoxia are not correlated with local
metabolite content in human melanoma xenografts with similar vascular
network
M Kroegerl, S Walental, EK Rofstad2 and W Mueller-Klieser'
'Institute ofPhysiology and Pathophysiology, University ofMainz, D-S5099 Mainz, Germany; 2Institutefor Cancer Research, The
Norwegian Radium Hospital, Montebello, N-0310 Oslo, Norway.
Summary Investigations were carried out on two lines of human melanomas (MF; n = 12 and EE; n = 13)
xenografted in nude mice. The tumours were characterised by a similar vascular supply but showed a
pronounced difference in the rate of volume growth and in the radiobiologically hypoxic fraction. The
distribution of ATP, glucose and lactate in the tumours was investigated using quantitative bioluminescence
and single photon imaging. Concentrations of the metabolites were obtained as global values for the entire
tumour mass, in regions with densely packed, structurally intact tumour cells ('viable zones'), in areas with
necrosis, stromal cells and fibrous material ('necrotic zones') and in adjacent normal tissue. In all melanomas
investigated glucose concentrations were significantly lower and lactate concentrations were significantly higher
than in normal tissue. In contrast, no significant differences for ATP were detected. ATP and glucose
concentrations were significantly less in necrotic than in viable tumour zones, whereas lactate concentrations
were nearly equal in these tumour parts. Corresponding results were obtained in central versus peripheral
tumour zones. There was no dependency ofglobal or regional metabolite concentrations on tumour size within
the volume range 110-1470 mm3. Based on this lack of dependency, metabolic concentrations were averaged
over the whole tumour size range. Metabolite concentrations were not significantly different either globally or
regionally between the two tumour entities investigated, a finding which held true for all three metabolites
registered. Thus, metabolite distributions apparently mirror the similarity in vascularity of MF and EE
melanomas rather than reflecting intrinsic properties with regard to tumour growth rates or susceptibility to
radiation.
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The significance of pathophysiological parameters for pre-
diction of the biological and therapeutic behaviour of
tumours is subject to ongoing debates in cancer research. A
large variety of partially confficting results has been
documented by a number of scientific groups depending,
among other factors, on the respective tumour model, the
registered biological and physiological parameters, the treat-
ment modality or the therapeutic end point.
Clinical studies have identified oxygen tension measured
with polarographic needle electrodes as a predictive par-
ameter for the outcome of radiation therapy in head and
neck cancer and cervix cancer (Gatenby et al., 1988; Hockel
et al., 1991, 1993; Vaupel et al., 1991). Although no data on
blood perfusion or vascular density were accessible in those
investigations, it can be concluded from numerous other
reports (reviewed in Vaupel et al., 1989) that differences in
nutritive supply accounted for the variations in the oxygena-
tion status of those tumours in patients. In a comprehensive
study on human tumour xenografts, Kallinowski et al. (1989)
found that the growth rate of a variety of different tumour
entities was positively correlated with tumour blood flow,
and that therapeutically relevant parameters of the metabolic
micromilieu largely depended on the efficacy of tumour per-
fusion. Unfortunately, no data on the responsiveness to treat-
ment of those xenografted tumours were available to enable
a direct comparison between physiological and therapeutical
parameters.
In an extensive study on growth kinetics, vascular morph-
ology as well as radio- and thermosensitivity, Rofstad et al.
have characterised the biology and therapeutic responsiveness
of two types of human melanoma xenografts (Rofstad and
Brustad, 1981, 1986; Solesvik et al., 1982, 1984; Rofstad,
1984, 1989a,b). The findings indicate that these tumours
show a similar vascular geometry, yet exhibit a largely
different volume growth rate and a corresponding difference
in the radiobiologically hypoxic fraction. Several mechanisms
may explain this discrepancy: it may be hypothesised that
morphometric parameters do not reflect the efficiency of
nutritive blood flow in these malignancies. Also, metabolic
turnover rates may be different between the two tumour
groups. In both cases, the metabolic milieu may be different
between the two tumour classes with one tumour type being
radioresistant, thermosensitive and slowly growing and the
second type showing opposite properties. The present
investigation was undertaken to clarify whether the metabolic
milieu was different in these human melanoma xenografts
and whether such differences could account for the variation
in tumour growth and radiobiological hypoxia. Since this
approach includes a comparison with data from previous
investigations on these tumour systems, i.e. the MF and EE
melanoma xenografts, a succinct summary of findings is
given in Table I. Among the characteristics that are relevant
for the present study the difference in the tumour volume
doubling time is most striking, 4.4 days for EE and 20.0 days
for MF melanomas at volumes of 200 mm3. Also, the
radiobiologically hypoxic cell fraction (mean ± s.e.) is low
(6 ± 3%) in EE tumours compared with the MF entity
(45 ± 17%). There were no statistically significant differences
in vascular density or proportion of necrosis between rapidly
and slowly growing melanomas (Solesvik et al., 1982; Rofs-
tad, 1984, 1989b).
Metabolic mapping, in particular geographical mapping of
ATP, using quantitative bioluminescence and single photon
imaging has generated metabolite distributions that closely
reflected the oxygenation status and the efficacy of micro-
circulation in various tumour types (Kroeger et al., 1991;
Kuhnle et al., 1992; Walenta et al., 1992; Schaefer et al.,
1993). Therefore, this technique was employed to determine
the distribution of metabolites, such as ATP, glucose and
lactate, in the two groups of human melanomas with a
spatial resolution at a microscopical level. The metabolites
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Table I Biological characteristics of MF and EE human melanoma xenografts
MF tumour EE tumour References
Radiobiologically
hypoxic cell fractiona (%) 45 ± 17 6 ± 3 Rofstad, 1989b
Volume doubling time (days) 20.0 4.4 Solesvik et al., 1982
Total vessel lengthab (mm mm-3) 36 ± 2 46 ± 2 Solesvik et al., 1982
Total vessel surfaceab (mm2 mm-3) 2.2 ± 0.1 2.5 ± 0.2 Solesvik et al., 1982
Total vessel volumeab (mm3 mm-3) 0.015 ± 0.001 0.015 ± 0.002 Solesvik et al., 1982
Mean vessel diametera (pm) 18.8 ± 0.5 16.9 ± 0.5 Solesvik et al., 1982
Necrotic fractiona (%) 43 + 4 32 + 2 Solesvik et al., 1982
Thermosensitivity High Low Rofstad and Brustad, 1986
aMean ± s.e. bPer unit histologically intact tumour volume.
could be registered within distinct tissue areas, i.e. within
viable tumour regions, within necrotic and stromal areas and
in adjacent normal tissue.
Materials and methods
Investigations were carried out on 12 MF and 13 EE
melanomas that were derived from lymph node metastases of
patients and xenografted in female BALB/c-nu/nu/BOM
mice (Solesvik et al., 1982, 1984; Rofstad, 1984). The
tumours were implanted s.c. into the flanks of the nude mice
and were used for measurements at volumes ranging from
110 to 1470mm3 as determined with the caliper method.
Tumour-bearing animals were kept under standardised con-
ditions at the Norwegian Radium Hospital as described
previously (Solesvik et al., 1982). At certain sizes tumours
were rapidly frozen in situ by contact with a brass block that
was precooled in liquid nitrogen. After excision of the entire
tumour mass including adjacent muscle and skin, the samples
were put on dry ice and were immediately shipped to the
Pathophysiology Division at the University of Mainz. There,
tumours were sealed in airtight bags to prevent freeze-drying
and were kept at -80°C until measurement.
The distribution of metabolite concentrations within the
tumours was assessed by single photon imaging and quan-
titative bioluminescence (Mueller-Klieser et al., 1988; Wal-
enta et al., 1990; Mueller-Klieser and Walenta, 1993). For
measurement, cryosections made from the frozen tumours
were adhered to the upper side of a cover glass. The cover
glass was laid upside down upon a glass slide with a rectan-
gular casting mould. The mould was filled with a frozen
enzyme solution. The solution contained luciferase and other
enzymes that link the substrate of interest to the luciferase
light reaction. Different mixtures of enzymes and luciferases
had to be used for determination of ATP, glucose, and
lactate. Applying these enzyme solutions to serial sections,
the metabolites could be determined at quasi-identical loca-
tions within the tumours.
The luciferase reaction with light emission started by rais-
ing the temperature of the whole array above the melting
point by positioning the glass slides into a thermostated
chamber on a microscope stage. The spatial distribution of
the bioluminescence intensity within the tissue section was
measured directly using an appropriate microscope (Axio-
phot, Zeiss, Oberkochen, Germany) and an imaging photon
counting system (ARGUS 100, Hamamatsu, Herrsching,
Germany).
After calibration with appropriate standards, two-dimen-
sional density distributions were obtained representing the
distribution of ATP, glucose, or lactate in absolute volume-
related tissue concentrations (pmol g-' wet weight). These
values were routinely confirmed by independent measure-
ments with high performance liquid chromatography (HPLC)
and enzymatic standard assays respectively. The optical over-
lay of an adjacent tissue section stained with haematoxylin
and eosin on the bioluminescence distribution made it possi-
ble to evaluate the metabolites in tumour regions with
densely packed, viable cancer cells designated 'viable zones';
in areas with necrosis and stromal tissue elements termed
'necrotic zones', in peripheral vs central tumour parts; and in
adjacent non-tumoric tissue, termed 'normal'. The last tissue
type consisted of connective tissue, fat, and skin muscle.
Further details on the technique of bioluminescence and
imaging photon counting have been published elsewhere
(Mueller-Klieser and Walenta, 1993).
For each tumour, up to five single determinations for each
substrate were performed and the concentration values were
averaged for each histologically classified tissue area. The
relative coefficient of variation of these determinations was
typically less than 10%; thus, no standard deviation was
included for these values.
For further evaluation, those concentration values of single
tumours were subsequently averaged for each tumour type
and classified tissue area and were given as mean ± s.d.
Concentrations in corresponding tissue areas of the two
tumour groups were compared by the Mann-Whitney U-
test, whereas the Wilcoxon test for paired observations was
used for the analysis ofdifferences between regions within the
tumour sections (e.g. viable vs necrotic areas). The depend-
ency of average metabolite concentrations on tumour volume
was tested by calculating Spearman's correlation coefficient
rs.
Results
As in previous studies with bioluminescence imaging in
various types of tumours, metabolite distributions measured
in MF and EE human melanoma xenografts were very
heterogeneous and partially reflected the chaotic histological
architecture of the malignancies. As mentioned in Materials
and methods, the data of all tumours were pooled for each
xenograft type and expressed as mean ± s.d. No significant
differences between the ATP concentrations averaged over
the whole tumour tissue and the adjacent normal tissue were
found in the MF and EE xenografts (Figure la). Concentra-
tion values of glucose were significantly less in the tumour
than in the adjacent normal tissue (Figure lb). In contrast,
opposing results were obtained for the distribution of lactate
(Figure 1c). Across the two tumour lines mean concentra-
tions of all three metabolites in corresponding tissue areas
were very similar. Only ATP values obtained in adjacent
normal tissue were significantly different between MF and
EE xenografts (P < 0.05).
ATP and glucose concentrations were significantly less in
necrotic than in viable tumour areas, whereas lactate concen-
trations were nearly equal in these tumour parts. This was
true in both MF and EE melanomas, as demonstrated in
Figure 2a-c. Only for EE xenografts, the lactate concentra-
tions showed a weak significant difference between viable and
necrotic tumour parts (P < 0.05). As described above forRadiobiological hypoxia and metabolites in human melanomas
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Figure 1 ATP, glucose and lactate concentrations (mean ± s.d.)
in whole tumour tissue (a) and in the adjacent normal tissue (0)
of MF (n = 12) and EE (n = 13) human melanoma xenografts.
Significant differences between tumour and normal tissue are
indicated by stars: **, P< 0.01 and ***, P< 0.001. Significant
differences across the two xenografts are indicated by triangle: A,
P < 0.05. (a) ATP, (b) glucose, (c) lactate.
values averaged over the entire tumour mass, statistically
significant differences between MF and EE tumours were not
seen for any of the three metabolites (P>0.1).
The evaluation of metabolite concentrations in peripheral
vs central tumour areas resulted in data shown in Figure 3.
ATP and glucose concentrations were significantly less in
central as compared with peripheral zones. No differences
were found for lactate, although there was a tendency for
higher values in the tumour centre. These findings were
obtained in both MF and EE melanomas. Significant
differences between the two tumour lines were not registered
for any of the metabolites.
Since ATP, glucose and lactate concentrations obtained in
the tumour areas showed no significant differences between
the two melanoma lines investigated, the values of single
tumours from the two entities were pooled for each
metabolite and each mode of determination and were inves-
tigated for their dependence on tumour size. Figure 4 shows
that there was no correlation between ATP, glucose and
lactate concentrations obtained in whole tumour areas of
single malignancies and tumour volume. As indicated by
Spearman's correlation coefficient, no size dependencies were
obvious for the concentrations of the three metabolites in
viable and necrotic tumour regions or in normal tissue. An
example is illustrated in Figure 5 showing ATP concentrat-
ions in viable (open symbols) and necrotic (solid symbols)
tumour areas as a function of tumour volume.
Discussion
The results of the present study clearly show that there is no
statistically significant or biologically relevant difference in
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Figure 2 ATP, glucose and lactate concentrations (mean + s.d.)
in tumour region with densely packed viable cancer cells (U) and
in areas with necrosis, connective and stromal tissue (0) of MF
(n = 12) and EE (n = 13) human melanoma xenografts.
Significant differences are indicated by stars: *, P < 0.05 and **,
P < 0.01. (a) ATP, (b) glucose, (c) lactate.
the metabolic micromilieu between the two types of human
melanoma xenografts investigated. Obviously, the distribu-
tion of ATP, glucose, and lactate reflect the similarity in the
vascular density between the two tumour groups rather than
the relatively drastic difference in volume growth kinetics.
Previous investigations with bioluminescence imaging on
hamster melanomas demonstrated that the local tissue con-
centration of ATP was positively correlated with the regional
perfusion (Walenta et al., 1992). If one assumes that the
morphometric data on the vascularity of the melanomas
investigated in this study are representative of the functional
state of tumour microcirculation, then similar metabolic mic-
roenvironments can in fact be expected in these melanomas.
The conclusions made above are true under the assump-
tion that the efficacy of supply is the key modulator of the
metabolic milieu in solid tumours, as it has been demon-
strated for several types of human tumour xenografts (Kal-
linowski et al., 1989). In those tumours, high blood flow rates
were associated with high metabolic turnover rates and rapid
tumour growth. Despite high oxygen consumption rates, the
oxygenation status was best in cancers with high-flow rates
and fast growth, whereas substantial hypoxia with an oxygen
pressure smaller than 5 mmHg was found only in poorly
perfused malignancies. The findings of the present investiga-
tion suggest that tumours can differ greatly in their growth
rate, although their situation with regard to vascular supply
and metabolic milieu may be very similar. Obviously, blood
supply meets the requirements for the unrestricted expression
of intrinsic growth properties in both the tumour entities
studied. In such a case, neither vascular parameters, nor data
on blood perfusion or the metabolic state of the tumours
would allow for a prediction of the rate of tumour expan-
sion. The conclusion is supported by the finding, that EE and
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Figure 3 ATP, glucose and lactate concentrations (mean ± s.d.)
in peripheral (U) and central (0) tumour regions of MF (n = 12)
and EE (n = 13) human melanoma xenografts. Significant differ-
ences between both regions are indicated by stars: *, P < 0.05, **,
P < 0.01 and ***, P < 0.001. (a) ATP, (b) glucose, (c) lactate.
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MF cells in monolayer culture have significantly different cell
number doubling times of 15 h and 35 h respectively (EK
Rofstad et al., unpublished results).
There is a striking difference in the radiobiologically
hypoxic fraction of the two melanoma lines that cannot be
explained on the basis of the present data. Although oxygen
tension values in these tumours are presently unknown, the
congruity of vascular density and metabolite distributions in
the two melanoma types argues against profound differences
in tumour oxygenation. This conclusion is strongly supported
by previous investigations comparing tissue oxygenation of
various solid tumours as quantified by cryospectrophoto-
metry with intratumoral concentrations of ATP measured
with bioluminescence (Mueller-Klieser et al., 1990). ATP was
positively correlated with tissue oxygenation status across the
different tumour lines in that experimental series. Inter-
mediate hypoxia can probably not explain the apparent dis-
crepancy between radiobiological hypoxia and metabolic
milieu in these tumours since recent data have indicated that
human melanoma xenografts do not show significant tran-
sient perfusion (Tufto and Rofstad, 1995). On the basis of
the present data one can assume that the metabolic mic-
romilieu, i.e. the tissue concentration of oxygen and meta-
bolites, is identical in both xenograft types. Therefore, the
striking differences in the radiobiologically hypoxic fraction
and the volume growth rate cannot be related to the vascular
supply and must be explained by differences in the intrinsic
properties of both tumours.
The bioluminescence method only allows for the measure-
ment of steady state concentrations of metabolites. Thus, one
possible explanation could be an intrinsically different meta-
bolic turnover rate in both tumour types, which cannot be
registered with the bioluminescence method. This explanation
is in accordance with the volume growth rate in vivo and the
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Figure 4 ATP, glucose and lactate concentrations values aver-
aged over whole tumour areas of MF (0) and EE (A) human
melanoma xenografts as a function of tumour volume. (a) ATP,
(b) glucose, (c) lactate. Each symbol represents the mean concent-
ration value for one tumour obtained from up to five single
measurements. Since the relative coefficient of variation of these
determinations was typically less than 10%, no standard devia-
tion is included.
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Figure 5 ATP concentrations in viable (open symbols) and nec-
rotic (solid symbols) tumour regions of MF (circles) and EE
(triangles) human melanoma xenografts as a function of tumour
volume. Each symbol represents the mean concentration value for
one tumour obtained from up to five single measurements. Since
the relative coefficient of variation of these determinations was
typically less than 10%, no standard deviation is included.
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cell growth rate in vitro. In addition, tumour cells in MF
xenografts with lower metabolic turnover rates may survive
hypoxic supply conditions for a longer time, leading to a
higher radiobiologically hypoxic fraction as compared with
EE tumours.
The major advance in using metabolic imaging with bio-
luminescence as compared with previous approaches is the
accessibility of structure-associated information on the func-
tional state of biological tissue. In most cases, the technique
allows for a highly resolved distinction between data
acquired in malignancies and values measured in surrounding
normal tissue. The concentrations of ATP and glucose were
significantly lower in necrotic tumour regions with stromal
elements as compared with areas with densely packed viable
cancer cells, whereas lactate concentrations were equal or
showed only a weak difference in these zones. Consequently,
the distribution of ATP and glucose mirrored the geometry
of these two 'classes' of tumour regions contrasted by lactate
distributions that seemed to be relatively unrelated to the
tissue architecture. Accordingly, the finding of significantly
less ATP and glucose in the tumour centre compared with
the periphery may reflect a different proportion of necrotic
tissue in outer and inner tumour regions. Preliminary data
obtained with the bioluminescence technique in biopsies of
cervical cancers are indicative of structure-related patterns of
all three metabolites in those malignancies (Mueller-Klieser et
al., 1994). Considering the regional evaluation ofmetabolites,
the absence of any significant difference in the global
metabolite concentrations between the two melanoma lines is
consistent with the determination of similar necrotic fractions
in these cancers (Solesvik et al., 1982).
The present study documents no significant changes of the
measuring parameters as a function of tumour size. This
result may indicate no change in the proportion of necrotic
vs viable tissue as the tumours increase in, volume. On the
other hand, a relatively high ATP content in the necrotic
region is indicative of some residual metabolic activity in
those areas. Investigations on multicellular tumour spheroids
have also revealed such a residual metabolic turnover in
regions that may be identified as being necrotic by his-
tological criteria (Walenta et al., 1990). Taking into account
the absence of correlation, it seems reasonable to calculate
averages irrespective of tumour volume for the parameters
considered here.
In conclusion, quantitative bioluminescence with single
photon imaging offers the possibility of regional and
structure-related evaluation of metabolite concentrations in
biological tissue. The application of this technique in two
lines of human melanoma xenografts with similar vascularity,
yet different growth rates and different. radiobiologically
hypoxic fractions resulted in metabolite distributions that
were not statistically different. Thus, the measured metabolite
concentrations reflect the efficiency of tumour blood per-
fusion and do not necessarily predict intrinsic growth
behaviour or therapeutic sensitivity of tumours.
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